Which pharmacological feature best distinguishes morphine from codeine among the naturally occurring opioids?

Explanation

## Distinguishing Morphine from Codeine ### Metabolic Pathway Difference **Key Point:** Codeine is a naturally occurring opioid that is a **prodrug**—it undergoes hepatic O-demethylation (catalyzed by CYP2D6) to form **morphine**, which is responsible for most of its analgesic and opioid effects. **High-Yield:** This metabolic conversion is the single most important pharmacological distinction between these two natural opioids. Codeine itself has weak mu-receptor affinity; morphine (its active metabolite) is 200× more potent at the mu receptor. ### Clinical Implications | Feature | Morphine | Codeine | |---------|----------|----------| | **Receptor affinity** | High (direct agonist) | Low (weak agonist) | | **Primary source of effect** | Direct binding | Metabolite (morphine) | | **CYP2D6 dependency** | None | Critical | | **Genetic variability** | Minimal impact | Significant (poor metabolizers get no analgesia) | | **Potency** | 1× (reference) | 1/200th (as codeine itself) | **Clinical Pearl:** Patients who are CYP2D6 poor metabolizers receive **no analgesic benefit** from codeine because they cannot convert it to morphine. This explains why codeine efficacy varies widely in populations. **Warning:** Codeine is NOT a prodrug in the sense that the parent compound is inactive—codeine itself has weak opioid activity, but the majority of its clinical effect comes from morphine formation. ### Why Other Options Are Incorrect - **Option 1 (correct):** Codeine → morphine via O-demethylation is the defining metabolic feature. - **Option 2:** Both drugs have similar protein binding (~35%); duration is determined by metabolism and clearance, not protein binding alone. - **Option 3:** Both produce respiratory depression at therapeutic doses; this is not a distinguishing feature. - **Option 4:** Morphine is NOT a prodrug—it is the active parent compound that exerts direct effects.